ARNT PROTEIN FUNCTION IN ANGIOGENESIS AND HEMATOPOIESIS
ARNT 蛋白在血管生成和造血中的功能
基本信息
- 批准号:6363585
- 负责人:
- 金额:$ 29.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-15 至 2004-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Verbatim from investigator's abstract): Angiogenesis and
hematopoiesis are functionally related processes that generate the vessels and
blood cells of the circulatory system. Recent data have demonstrated that
oxygen deprivation (hypoxia), in addition to developmentally regulated signals,
is a potent activator of angiogenesis and hematopoiesis. To investigate the
molecular mechanisms whereby hypoxia regulates these processes, mutations have
been generated in the murine Arnt gene, which encodes a bHLH-PAS transcription
factor. ARNT protein regulates the expression of Epo, VEGF and other
angiogenesis-related genes through interactions with its heterodimeric partner,
HIF-1alpha. Arnt -/- ES cells fail to upregulate may target genes under hypoxic
conditions, and Arnt-/- mutant embryos are arrested in development at embryonic
day E9.5-10.5, apparently due to vascular abnormalities in the placenta, yolk
sac and embryo itself. More recently, it has been shown that the Arnt -/-
mutation also disrupts normal hematopoiesis in yolk sac blood islands. A
second, highly related murine Arnt gene (Arnt 2) has recently been described.
Although expressed in a strikingly different spatial pattern than Arnt 1 in
embryonic and adult mice, it is possible that Arnt 2 may partly compensate for
the loss of the Arnt protein in Arnt -/- mutant embryos. It is proposed to
generate and analyze Arnt 2 -/- and Arnt -/-, Arnt 2-/- double mutant mouse
strains, which will address many important questions regarding the role of both
Arnt and Arnt2 in mediating hypoxia-induced angiogenesis and hematopoiesis. As
hypoxic responses are more important in a variety of pathologies, including
post-ischemic neovascularization and tumor cell apoptosis, the results of these
experiments should prove valuable in developing clinical approaches in the
future. At a basic level, they will provide important information oon
hypoxia-induced transcriptional regulation that complements our rapidly
expanding understanding of receptor/ ligand signalling in angiogenesis and
hematopoiesis.
描述(逐字摘自研究者摘要):血管生成和
造血是产生血管的功能相关过程,
循环系统的血细胞。最近的数据表明,
缺氧(缺氧),除了发育调节信号,
是血管生成和造血的有效激活剂。探讨
缺氧调节这些过程的分子机制,突变具有
在编码bHLH-PAS转录的鼠Arnt基因中产生
因子ARNT蛋白调节Epo、VEGF和其他细胞因子的表达。
通过与其异源二聚体配偶体的相互作用,
缺氧诱导因子-1 α。Arnt -/- ES细胞在缺氧条件下不能上调可能的靶基因
条件下,Arnt-/-突变胚胎在胚胎发育中被阻止,
E9.5-10.5天,显然是由于胎盘、卵黄
胚囊和胚本身。最近,已经表明Arnt -/-
突变还破坏卵黄囊血岛中的正常造血。一
其次,最近描述了高度相关的鼠Arnt基因(Arnt 2)。
虽然在一个与Arnt 1显著不同的空间模式中表达,
在胚胎和成年小鼠中,Arnt 2可能部分补偿了
Arnt -/-突变胚胎中Arnt蛋白的丢失。提出要
制备并分析Arnt 2 -/-和Arnt -/-、Arnt 2-/-双突变小鼠
菌株,这将解决许多重要的问题,关于双方的作用
Arnt和Arnt 2介导缺氧诱导的血管生成和造血。作为
缺氧反应在多种病理中更为重要,包括
缺血后新生血管和肿瘤细胞凋亡,这些结果
实验应该证明在开发临床方法方面是有价值的。
未来在基本层面上,它们将提供关于
缺氧诱导的转录调节,补充我们的迅速
扩大对血管生成中受体/配体信号传导的理解,
造血
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. CELESTE SIMON其他文献
M. CELESTE SIMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. CELESTE SIMON', 18)}}的其他基金
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
胰腺癌肿瘤邻域的基质和血管输入
- 批准号:
10733718 - 财政年份:2023
- 资助金额:
$ 29.97万 - 项目类别:
HIF-1alpha and FBP2 in sarcoma metabolism, progression, and metastasis
HIF-1α 和 FBP2 在肉瘤代谢、进展和转移中的作用
- 批准号:
9263282 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
肾癌中的代谢肿瘤抑制剂:在疾病进展中发挥前所未有的作用
- 批准号:
9975793 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
肾癌中的代谢肿瘤抑制剂:在疾病进展中发挥前所未有的作用
- 批准号:
9390182 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
Metabolic Influences on Complex Tumor Neighborhoods
代谢对复杂肿瘤邻近区域的影响
- 批准号:
10737396 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
HIF-1alpha and FBP2 in sarcoma metabolism, progression, and metastasis
HIF-1α 和 FBP2 在肉瘤代谢、进展和转移中的作用
- 批准号:
10059906 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
肾癌中的代谢肿瘤抑制剂:在疾病进展中发挥前所未有的作用
- 批准号:
10214558 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
肾癌中的代谢肿瘤抑制剂:在疾病进展中发挥前所未有的作用
- 批准号:
10456722 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
HIF-1alpha and FBP2 in sarcoma metabolism, progression, and metastasis
HIF-1α 和 FBP2 在肉瘤代谢、进展和转移中的作用
- 批准号:
10080711 - 财政年份:2017
- 资助金额:
$ 29.97万 - 项目类别:
HIFs and VEGF in sarcoma progression, metastasis, and radiation response
HIF 和 VEGF 在肉瘤进展、转移和放射反应中的作用
- 批准号:
8332256 - 财政年份:2011
- 资助金额:
$ 29.97万 - 项目类别:
相似海外基金
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056554 - 财政年份:1990
- 资助金额:
$ 29.97万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056556 - 财政年份:1989
- 资助金额:
$ 29.97万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056555 - 财政年份:1988
- 资助金额:
$ 29.97万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056553 - 财政年份:1987
- 资助金额:
$ 29.97万 - 项目类别:
The Athymic Mouse As a Model For the Study of Keloids
无胸腺小鼠作为瘢痕疙瘩研究的模型
- 批准号:
7816691 - 财政年份:1978
- 资助金额:
$ 29.97万 - 项目类别:
Standard Grant